Osteoporosis: catching a time bomb among the elderly

October 02, 2000

Osteoporosis produces no symptoms and the disease is very difficult to detect before a fracture occurs. However, once that first fracture does occur treatment remains especially important and valuable, since the rate of clinically serious fractures of the hip and spine increases as much as 20-fold after the first fragility fracture.

In this study, Ernest Hajcsar and colleagues surveyed 228 patients who had presented to Ontario fracture clinics with fractures associated with bone fragility. The authors sought to determine whether the patients had been treated for osteoporosis. Of the 108 eligible patients who responded, only 20 (18.5%) had received a diagnosis of osteoporosis either before or within 1 year of the fracture and 43 (39.8%) had experienced previous fractures. Of the 20 who received a diagnosis of osteoporosis, 8 (40%) were taking hormone replacement therapy and 8 (40%) were taking bisphosphonates; the corresponding numbers among those undiagnosed were 4 (4.5%) and 0.

The authors report that since so few patients had received a proper diagnosis, and fewer still were receiving appropriate therapy, these findings represent an "important lost opportunity to build bone mass and reduce fracture risk in a large patient population." The study is considered important because of the demographic bulge created by Canada's baby boomers, in whom osteoporosis will represent a serious problem.
Investigation and treatment of osteoporosis in patients with fragility fractures -- E.E. Hajcsar et al
Contact: Dr. Earl Bogoch is a Professor in the Department of Surgery, St. Michael's Hospital, University of Toronto

Canadian Medical Association Journal

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.